Johnson & Johnson Sued Over Failing To Deliver Promised Post-Merger Returns To Auris Investors
Johnson & Johnson (NYSE: JNJ) stands accused in a lawsuit of deceiving investors regarding performance-based earnings from Auris Health Inc, a medical-robot company it acquired last year for $5.7 billion, Bloomberg
